SA’s Biovac begins production of Pfizer-BioNTech COVID-19 vaccine in early 2022
After receiving the drug substance from Europe, South Africa’s Biovac Institute will begin manufacturing Pfizer-(PFE.N), BioNTech’s (22UAy.DE) COVID-19 vaccine early next year, according to a Pfizer executive. Biovac’s July “fill …
Read More